In Phase A, members will receive diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing program. Additional contributors will likely be enrolled within the determined monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In https://olivery111lwh4.homewikia.com/user